腔道介入联合小剂量他达拉非治疗慢性前列腺炎伴勃起功能障碍的临床研究进展  

Clinical research progress of orifices in combination with small dose of Tadalafll in the treatment of chronic prostatitis with erectile dysfunction

作　　者：范从彬 陈建华[1] 陈巍巍[1] 刘建国[1] 

机构地区：[1]江苏省如皋市中医院泌尿男科,江苏如皋226500

出　　处：《医药前沿》2016年第23期13-14,共2页Journal of Frontiers of Medicine

摘　　要：CP合并ED是男科常见病，多发病，在一定程度上影响了患者的身心健康。当前，该疾病的发病率呈现出了逐年上升的趋势，使用有效方式，对患者实施个性化治疗有着极其重要的现实意义。结合实际情况，本文全面探究使用腔道介入联合小剂量他达拉非治疗CP合并ED的临床效果，报告如下。The CP merger male ED is a common disease, frequently-occurring disease. The symptoms to a certain extent, affects the patient＇s physical and mental health. At present, the incidence of the disease revealed a rising trend year by year. Use effective way, implement individualized treatment for patients, has extremely important practical significance. Combined with the actual situation, this paper comprehensively expounds the use tract involvement in combination with small dose of Tadalafil for the treatment of CP combined ED.

关 键 词：腔道介入性治疗 他达拉非 慢性前列腺炎 勃起功能障碍 

分 类 号：R697.3[医药卫生—泌尿科学]